Samik Pharm Co EBITDA per Share

What does Samik Pharm Co do? Samik Pharm Co Ltd manufactures and sells pharmaceutical products including Cesar Plus tablets for circulatory system treatments, Eravix tablets, Griffin tablets for diabetes, Gluemser tablets, Samik Pharmotidine tablets for digestive issues, Rebacode tablets, Tamitrasemi tablets, and Seklfen tablets as antipyretic anti-inflammatory drugs. The company also produces medications for treating acute vaginal candidiasis, motion sickness in children, and alopecia. Products are sold domestically in Korea and internationally. The firm's revenue comes from the sale of these branded pharmaceutical products to healthcare providers and pharmacies in both domestic and international markets. Key product lines include cardiovascular, diabetes, digestive health, and anti-inflammatory treatments, alongside specialized medications for specific conditions like vaginal candidiasis and motion sickness. The company targets healthcare professionals and consumers seeking treatment for these medical conditions through its domestic and global distribution channels. Samik Pharm Co Ltd's business model relies on the manufacturing and global distribution of its branded pharmaceutical products. The company focuses on delivering targeted treatments for circulatory, diabetes, digestive, and inflammatory conditions, as well as specialized solutions for vaginal candidiasis, motion sickness, and alopecia. Its products are marketed to healthcare providers and end consumers across Korea and overseas markets, generating revenue through direct sales and distribution agreements. Samik Pharm Co is one of the most popular companies on Eulerpool.